UniSuper Management Pty Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1989400 MELBOURNE, VICTORIA, C3

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,045,378

+$418,445 QoQ

Shares Held

11,299

+31.7% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#343

of 1,322 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UniSuper Management Pty Ltd holds $27,620,777 across 8 Biotechnology names. REGN ranks #2 (25.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	27,989	$13,902,975
2	REGN	Regeneron Pharmaceuticals, Inc. This page	11,299	$7,045,378
3	INCY	Incyte Corp	15,515	$1,758,780
4	MRNA	Moderna, Inc.	23,601	$1,652,778
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,687	$1,109,897
6	RVMD	Revolution Medicines, Inc.	4,589	$859,427
7	TECH	BIO-TECHNE Corp	10,616	$750,020
8	INSM	INSMED Inc	5,079	$541,522

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,045,378	11,299	+31.7%	Shares	Sole	2026-08-14
2026-03-31	$6,626,933	8,577	-0.7%	Shares	Sole	2026-05-11
2025-12-31	$6,668,184	8,639	-9.6%	Shares	Sole	2026-02-12
2025-09-30	$5,374,738	9,559	+14.2%	Shares	Sole	2025-10-31
2025-06-30	$4,393,200	8,368	+7.3%	Shares	Sole	2025-07-22
2025-03-31	$4,948,262	7,802	+6.8%	Shares	Sole	2025-05-15
2024-12-31	$5,204,282	7,306	+38.0%	Shares	Sole	2025-02-12
2024-09-30	$5,564,213	5,293	+2.8%	Shares	Sole	2024-11-14
2024-06-30	$5,411,753	5,149	+113.7%	Shares	Sole	2024-08-05
2024-03-31	$2,318,638	2,409	+174.1%	Shares	Sole	2024-05-13
2023-12-31	$772,016	879	-46.3%	Shares	Sole	2024-02-13
2023-09-30	$1,346,362	1,636	-10.8%	Shares	Sole	2023-11-13
2023-06-30	$1,317,802	1,834	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.